xTrimoPGLM-based antigen-specific antibody CDR-H3 design (PALM-H3)
Peer-reviewed| Поле | Значение |
|---|---|
| Authors | NR |
| Year | 2024 |
| Venue / status | Peer-reviewed journal; Nature Communications (Q1) |
| DOI | 10.1038/s41467-024-50903-y |
| URL | https://doi.org/10.1038/s41467-024-50903-y |
| Preprint URL | NR |
| Tools | PALM-H3 |
Задача и claimed novelty
| Поле | Значение |
|---|---|
| Main biological task | Antigen/epitope-conditioned CDR-H3 sequence generation |
| Claimed novelty | NR |
Архитектура
| Поле | Значение |
|---|---|
| Model architecture | Antigen encoder + autoregressive antibody decoder; A2binder predictor for ranking |
| Input representation | NR |
| Encoder / decoder | NR |
| Generative state | CDR-H3 sequence; grafted antibody candidates |
| Conditioning | CDR-H3 length/context; antigen epitope sequence |
| Sampling | NR |
Training
| Поле | Значение |
|---|---|
| Objectives / losses | NR |
| Dataset | NR |
| Preprocessing | NR |
Inference
NR
Baselines и retrospective benchmarks
| Поле | Значение |
|---|---|
| Baselines | NR |
| Retrospective | NR |
Prospective experimental validation
| Поле | Значение |
|---|---|
| Prospective | Binding and neutralization reported; predicted affinity outputs are not the experimental result |
| Tested designs | Generated antibodies tested against SARS-CoV-2 variants; exact final count: NR here |
| Success criterion | Binding and neutralization reported; predicted affinity outputs are not the experimental result |
| Main results | Binding and neutralization reported; predicted affinity outputs are not the experimental result |
Limitations
Single antigen family in prospective validation; sequence-only CDR generation; internal affinity predictor is not affinity improvement.
Что статья показывает
- Binding and neutralization reported; predicted affinity outputs are not the experimental result
Чего статья не показывает
- Predicted confidence, likelihood, pLDDT, docking or developability scores are not experimental affinity.
Размеченные утверждения
| Утверждение | Тип | Локатор |
|---|---|---|
| xTrimoPGLM-based antigen-specific antibody CDR-H3 design (PALM-H3) | Interpretation | DOI/URL from landscape matrix |
| Publication status: Peer-reviewed journal; Nature Communications (Q1) | Author-reported | landscape matrix, publication status column |
Review queue
- Bibliographic title must be verified against the PDF.
Source-grounded разбор статьи
Исследовательский вопрос
[MATRIX]Antigen/epitope-conditioned CDR-H3 sequence generation
Утверждения и поддержка evidence
[MATRIX]Claimed novelty: NR
[INTERPRETATION]Статья не «доказывает» общее преимущество метода вне своего экспериментального дизайна.
Что представленный evidence не поддерживает
- Predicted confidence, likelihood, pLDDT, docking or developability scores are not experimental affinity.
Ограничения, признанные авторами
[MATRIX]Single antigen family in prospective validation; sequence-only CDR generation; internal affinity predictor is not affinity improvement.
Дополнительные ограничения интерпретации
NRПока Methods/SI не прочитаны, нельзя утверждать split leakage, точные гиперпараметры и полноту ablation.